Skip to main content
SpringerLink
Log in

Liver Transplantation: Indications, Preoperative Evaluation and Posttransplantation Management

  • Chapter
Clinical Hepatology

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abt PL, Mange KC, Olthoff KM, et al (2004) Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant 4: 1302–7

    Article  PubMed  Google Scholar 

  2. Alamo JM, Gomez MA, Preja F, et al (2006) Morbidity and mortality in liver retransplantation. Transplant Proc 38: 2475–7

    Article  CAS  PubMed  Google Scholar 

  3. Anderson RD, Chimakotia S, Guo K, et al (2007) Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation. Clin Transplant 21: 510–7

    Article  PubMed  Google Scholar 

  4. Arguedas MR, Abrams GA, Krowka MJ, et al (2003) Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 37: 192–7

    Article  PubMed  Google Scholar 

  5. Baid S, Cosimi AB, Farrell MC, et al (2001) Posttransplant diabetes mellitus in liver transplant recipients. Transplantation 72: 1066–72

    Article  CAS  PubMed  Google Scholar 

  6. Baltz AC, Trotter JF (2003) Living donor liver transplantation and hepatitis C. Clin Liver Dis 7: 651–5

    Article  PubMed  Google Scholar 

  7. Basse G, Esposito L, Mengelle C, et al (2006) Predictive factors for cytomegalovirus infection after OLT using an ultrasensitive polymerase chain reaction. Transpl Proc 38: 2839–41

    Google Scholar 

  8. Bellamy CO, DiMartini AM, Ruppert K, et al (2001) Liver transplantation for alcoholic cirrhosis. Transplantation 72: 619–26

    Article  CAS  PubMed  Google Scholar 

  9. Berg CL, Gillespie BW, Merion RM, et al (2007) Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 133: 1806–13

    Article  PubMed  Google Scholar 

  10. Bismuth H, Majno PE, Adam R (1999) Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 19: 311–22

    Article  CAS  PubMed  Google Scholar 

  11. Blair JE, Kusne S (2005) Bacterial, mycobacterial, and protozoal infections after liver transplantation-part I. Liver Transpl 11: 1452–9

    Article  PubMed  Google Scholar 

  12. Brown RS, Lake JR (2005) The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution. Am J Transpl 5: 203–4

    Article  Google Scholar 

  13. Canzanello VI, Textor SC Taler SJ, et al (1998). Late hypertension after liver transplantation. Liver Transpl Surg 4: 328–34

    Article  CAS  PubMed  Google Scholar 

  14. Carithers RL Jr (2000) Liver transplantation. Liver Transpl 6: 122–35

    Article  PubMed  Google Scholar 

  15. Chahal P, Baron TH, Poterucha JJ, et al (2007) Endoscopic retrograde cholangiography in post-orthotopic liver transplant population with roux-en-y biliary reconstruction. Liver Transpl 13: 1168–73

    Article  PubMed  Google Scholar 

  16. Charlton M, Seaberg E, Wiesner R, et al (1998) Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 28: 823–30

    Article  CAS  PubMed  Google Scholar 

  17. Charlton M, Ruppert K, Belle SH, et al (2004) Long-term results and modeling to predict outcomes in recipients with HCV infection. Liver Transpl 10: 1120–30

    Article  PubMed  Google Scholar 

  18. Colle IO, Moreau R, Godinho E, et al (2003) Diagnosis of portopulmonary hypertension in candidates for liver transplantation. Hepatology 37: 401–9

    Article  PubMed  Google Scholar 

  19. D'Alessandro AM, Ploeg RJ, Knechtle SJ, et al (1993) Retransplantation of the liver – a seven-year experience. Transplantation 55: 1083–7

    Article  PubMed  Google Scholar 

  20. Deminclean, Noureddine, Vigos, et al (1964) Tentative d'homogreffe hepatique. Mem Acad Chir 90: 177

    Google Scholar 

  21. Desai NM, Mange KC, Crawford MD, et al (2004) Predicting outcome after liver transplantation. Transplantation 77: 99–106

    Article  PubMed  Google Scholar 

  22. Dickson RG, Terrault NA, Ishitani M, et al (2006) Protective antibody levels and dose requirements for IV5% Nabi hepatitis immune globulin combined with lamivudine in liver transplantation for hepatitis B induced end stage liver disease. Liver Transpl 12: 124–33

    Article  PubMed  Google Scholar 

  23. Dumortier J, Bernard S, Bouffard Y, et al (2006) Conversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitus. Liver Transpl 12: 659–64

    Article  PubMed  Google Scholar 

  24. Everhart JE, Beresford TP (1997) Liver transplantation for alcoholic liver disease. Liver Transpl Surg 3: 220–6

    Article  CAS  PubMed  Google Scholar 

  25. Everson GT, Trotter J, Forman L, et al (2005) Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 42: 255–62

    Article  CAS  PubMed  Google Scholar 

  26. Figueras J, Ibanez L, Ramos E, et al (2001) Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis. Liver Transpl 7: 877–83

    Article  CAS  PubMed  Google Scholar 

  27. Fisher RA, Kulik LM, Freise CE, et al (2007) Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transpl 7: 1601–8

    Article  CAS  Google Scholar 

  28. Fishman JA, Emery V, Freeman R, et al (2007). Cytomegalovirus in transplantation -challenging the status quo. Clin Transpl 21: 149–58

    Article  Google Scholar 

  29. Freeman RB (2003) The impact of the model for end-stage liver disease on recipient selection for adult living donor liver donation. Liver Transpl 9: S54–S59

    Article  PubMed  Google Scholar 

  30. Freeman RB, Wiesner RH, Edwards E, et al (2004) Results of the first year of the new liver allocation plan. Liver Transpl 10: 7–15

    Article  PubMed  Google Scholar 

  31. Fung J, Eghtesad B, Patel-Tom K, et al (2004) Liver transplantation in patients with HIV infection. Liver Transpl 10: S39–53

    Article  PubMed  Google Scholar 

  32. Guchelberger O, Bechstein WO, Neuhaus R, et al (1997) Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation. Clin Transpl 11: 60–5

    Google Scholar 

  33. Heimbach JK, Haddock MG, Alberts SR, et al (2004) Transplantation for hilar cholangiocarcinoma. Liver Transpl 10: S65–8

    Article  PubMed  Google Scholar 

  34. Heisel O, Heisel R, Balshaw R, et al (2004) New onset diabetes mellitus in patients receiving calcineurin inhibitors. Am J Transpl 4: 583–95

    Article  Google Scholar 

  35. Hoppe L, Marroni CA, Bressane R, et al (2006) Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients. Transpl Proc 38: 1922–3

    Article  CAS  Google Scholar 

  36. Hopper C, Marroni CA, Bressare R, et al (2006) Impact of cytomegalovirus infection on long-term survival after ortho-topic liver transplantation. Transpl Proc 38: 1924–5

    Article  Google Scholar 

  37. Husain S, Tollemar J, Dominguez EA, et al (2003) Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients. Transplantation 75: 2023–9

    Article  PubMed  Google Scholar 

  38. International Panel (1997) Banff schema for grading liver allograft rejection. Hepatology 25: 658–63

    Article  Google Scholar 

  39. Iwesaki Y, Porter KA, Arend JR, et al (1967) The preparation and testing of horse antidog and antihuman antilym-phoid plasma on serum and its protein factors. Surg Gynecol Obstet 124: 1–24

    Google Scholar 

  40. John PR, Thuluvath PJ (2001) Outcome of liver transplantation in patients with diabetes mellitus. Hepatology 34: 889–95

    Article  CAS  PubMed  Google Scholar 

  41. Jonas S, Bechstein WO, Steinmuller T, et al (2001) Vascular invasion and histopathologic grading to determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33: 1080–6

    Article  CAS  PubMed  Google Scholar 

  42. Kamath PS, Wiesner RH, Malinchoc M, et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464–70

    Article  CAS  PubMed  Google Scholar 

  43. Kitazano MT, Qayyum A, Yeh BM, et al (2007) Magnetic resonance cholangiography of biliary structures after liver transplantation. J Magn Reson Imaging 25: 1168–73

    Article  Google Scholar 

  44. Klintmalm GB (1998) Liver transplantation for hepatocel-lular carcinoma. Ann Surg 228: 479–90

    Article  CAS  PubMed  Google Scholar 

  45. Kobashigawa JA, Khasiske BL (1997) Hyperlipidemia in solid organ transplantation. Transplantation 66: 331–8

    Article  Google Scholar 

  46. Koch DG, Christiansen L, Lazarchick J, et al (2007) Posttransplantation lymphoproliferative disorder — the great mimic in liver transplantation. Liver Transpl 13: 904–12

    Article  PubMed  Google Scholar 

  47. Laryea M, Watt KD, Molinari M, et al (2007) Metabolic syndrome and liver transplant recipients. Liver Transpl 13: 1104–14

    Article  Google Scholar 

  48. Lim JK, Keefe EB (2004) Liver transplantation for alcoholic liver disease. Liver Transpl 10: S31–8

    Article  PubMed  Google Scholar 

  49. Liu CL, Lam B, Lo CM (2003) Impact of right-lobe live donor liver transplantation on patients waiting for liver transplantation. Liver Transpl 9: 863–9

    Article  PubMed  Google Scholar 

  50. Llovet JM, Fuster J, Bruix J, et al (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma. Hepatology 30: 1434–40

    Article  CAS  PubMed  Google Scholar 

  51. Lo CM, Fan S, Liu C, et al (2004) The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 10: 440–7

    Article  PubMed  Google Scholar 

  52. Longheval G, Vereerstraeten P, Thiry P (2003) Predictive models of short- and long-term survival in patients with survival in patients with nonbiliary cirrhosis. Liver Transpl 9: 260–7

    Article  PubMed  Google Scholar 

  53. Lucey MR, Brown KA, Everson GT, et al (1997) Minimal criteria for placement of adults on the liver transplant waiting list. Liver Transpl Surg 3: 628–37

    Article  CAS  PubMed  Google Scholar 

  54. Luther P, Baldwin Jr. P (2004) Pioglitazone in the management of diabetes mellitus after transplantation. Am J Transpl 4: 2135–8

    Article  CAS  Google Scholar 

  55. Macedo G, Lopes S, Barroso S, et al (2003) Implementation of screening and preventive strategies in liver transplant candidates [Abstract]. Transpl Proc 35: 115

    Article  CAS  Google Scholar 

  56. Mandell MS (2004) Hepatopulmonary syndrome and por-topulmonary hypertension in the model for end-stage liver disease (MELD) era. Liver Transpl 10: S54–8

    Article  PubMed  Google Scholar 

  57. Marcos A, Fisher RA, Ham JM, et al (2000) Liver regeneration and function in donor and recipient right lobe adult living donor liver transplantation. Transplantation 69: 1375–9

    Article  CAS  PubMed  Google Scholar 

  58. Mazzaferro V, Regalia E, Doci R, et al (1996) Liver transplantation for hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 334: 693–9

    Article  CAS  PubMed  Google Scholar 

  59. McDiarmid SV, Anand R, Lindblad AS, et al (2002) Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 74: 173–81

    Article  PubMed  Google Scholar 

  60. Merion RM, Schaubel DE, Dykstra DM, et al (2005) The survival benefit of liver transplantation. Am J Transpl 5: 307–13

    Article  Google Scholar 

  61. Merion RM, Wolfe RA, Dykstra DM, et al (2003) Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 9: 12–8

    Article  PubMed  Google Scholar 

  62. Mirabella S, Brunati A, Ricchiuti A, et al (2005) New-onset diabetes after liver transplantation. Transpl Proc 37: 2636–7

    Article  CAS  Google Scholar 

  63. Moore FD, Birtch AG, Dagher F, et al (1964) Immuno-suppression and liver transplantation. Ann NY Acad Sci 120: 729–38

    CAS  PubMed  Google Scholar 

  64. Neal DA, Brown MJ, Wilkinson IB, et al (2005) Mechanisms of hypertension after liver transplantation. Transplantation 79: 935–40

    Article  PubMed  Google Scholar 

  65. Neuberger J, Schulz KH, Day C, et al (2002) Treatment for alcoholic liver disease. J Hepatol 36: 130–7

    Article  PubMed  Google Scholar 

  66. O'Grady J, Alexander GJ, Hayllar KM, et al (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97: 439–45

    PubMed  Google Scholar 

  67. Olthoff KM, Brown RS, Delmonico FL, et al (2004) Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl 10: A6–22

    Article  PubMed  Google Scholar 

  68. Osawa M, Ito Y, Hirai T, et al (2007) Risk factors for invasive aspergillosis in living donor liver transplant recipients. Liver Transpl 13: 566–70

    Article  PubMed  Google Scholar 

  69. Palumbo JD, Lopes SM, Zeisel SH, et al (1987) Effectiveness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end-stage liver disease. Gastroenterology 93: 1170–7

    Google Scholar 

  70. Pappas PG, Andes D, Schuster M, et al (2006) Invasive fungal infections in low-risk liver transplant recipients. Am J Transpl 6: 386–91

    Article  CAS  Google Scholar 

  71. Pfau PR, Kochman ML, Lewis JD, et al (2000) Endoscopic management of postoperative liver transplantation. Gastrointest Endosc 52: 55–63

    Article  CAS  PubMed  Google Scholar 

  72. Pugh RNH, Murray-Lion IM, Dawson JC, et al (1979) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 640–6

    Google Scholar 

  73. Ragni M, Belle SH, Im KA, et al (2003) Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 188: 1412–20

    Article  PubMed  Google Scholar 

  74. Rea DJ, Heimbach JK, Rosen CB, et al (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242: 451–8

    PubMed  Google Scholar 

  75. Rerknimitr R, Sherman S, Fogel EL, et al (2002) Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis. Gastrointest Endosc 55: 224–31

    Article  PubMed  Google Scholar 

  76. Rocca P, Cocuzza E, Rasetti R, et al (2003) Predictors of psychiatric disorders in liver transplantation candidates. Liver Transpl 9: 721–6

    Article  PubMed  Google Scholar 

  77. Roy A, Kneteman N, Lilly L, et al (2006) Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant. Transplantation 82: 494–500

    Article  CAS  PubMed  Google Scholar 

  78. Rubin RH, Wolfson JS, Cosimi AB, et al (1981) Infection in the renal transplant recipient. Am J Med 70: 405–11

    Article  CAS  PubMed  Google Scholar 

  79. Russo MW, Galanko J, Beavers K, et al (2004) Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 10: 340–6

    Article  PubMed  Google Scholar 

  80. Russo MW, LaPointe-Rudow D, Kinkhabwala M, et al (2004) Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantation. Am J Transpl 4: 427–31

    Article  Google Scholar 

  81. Safdar K, Neff GW, Montalbano M, et al (2004) Liver transplant for the septuagenarians. Transpl Proc 36: 1445–8

    Article  CAS  Google Scholar 

  82. Sala M, Fuster J, Llovet JM, et al (2004) High pathological risk of recurrence after surgical resection for hepatocellular carcinoma. Liver Transpl 10:1294–300

    Article  PubMed  Google Scholar 

  83. Sala M, Varela M, Bruix J (2004) Selection of candidates with hepatocellular carcinoma in the MELD era. Liver Transpl 10: S4–9

    Article  PubMed  Google Scholar 

  84. Saliba F, Lakehalm M, Pageaux GP, et al (2007) Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis c virus infection. Liver Transpl 13: 136–44

    Article  PubMed  Google Scholar 

  85. Sato T, Inagaki A, Uchida K, et al (2003) Diabetes mellitus after transplant. Transplantation 76: 1320–6

    Article  CAS  PubMed  Google Scholar 

  86. Sheiner PA, Magliocca JF, Bodian CA, et al (2000) Longterm medical complications in patients surviving ≥ five years after liver transplant. Transplantation 69: 781–9

    Article  CAS  PubMed  Google Scholar 

  87. Shimoda M, Farmer DG, Colquhoun SD, et al (2001) Liver transplantation for cholangiocellular carcinoma. Liver Transpl 7: 1023–33

    Article  CAS  PubMed  Google Scholar 

  88. Silva MA, Jambulingam PS, Gunson BK, et al (2006) Hepatic artery thrombosis following orthotopic liver transplant. Liver Transpl 12: 146–151

    Article  PubMed  Google Scholar 

  89. Singh N, Wagener MM, Obman A, et al (2004) Bacteremias in liver transplant recipients. Liver Transpl 10: 844–9

    Article  PubMed  Google Scholar 

  90. Starzl TE, Marchioro TL, Vonkaulla KN, et al (1963) Homotransplantation of the liver in humans. Surg Gynecol Obstet 117: 659–76

    CAS  PubMed  Google Scholar 

  91. Starzl TE, Marchioro TL, Rowldand DT, et al (1964) Immunosuppression after experimental and clinical homotransplantation of the liver. Ann Surg 160: 411–39

    Article  CAS  PubMed  Google Scholar 

  92. Starzl TE, Machioro TL, Porter KA, et al (1967) The use of heterologous antilymphoid agents in canine and in human renal homotransplantations. Surg Gynecol Obstet 124: 301–8

    CAS  PubMed  Google Scholar 

  93. Starzl TE, Murase M, Marcos M, et al (2005) History of liver and multivisceral transplantation. In: Bussuttil RW, Klintmalm GK (eds) Transplantation of the Liver. Elsevier Sanders, Philadelphia, PA

    Google Scholar 

  94. Steagall MD, Everson G, Schroter G, et al (1995) Metabolic complications after liver transplantation. Transplantation 60: 1057–60

    Google Scholar 

  95. Trotter JF (2000) Selection of donors and recipients for living donor liver transplantation. Liver Transpl 6: S52–8

    Article  CAS  PubMed  Google Scholar 

  96. Trotter JF, Wachs M, Trouillot T, et al (2000) Evaluation of 100 patients for living donor liver transplantation. Liver Transpl 6: 290–5

    Article  CAS  PubMed  Google Scholar 

  97. UNOS Policy 3 Appendix 3B http://www.unos.org/PoliciesandBylaws/policies/docs/policy_15.doc

  98. Veldt BJ, Lainé F, Guillygomarc'h A, et al (2002) Indications of liver transplantation in severe alcoholic liver cirrhosis. J Hepatol 36: 93–8

    Article  PubMed  Google Scholar 

  99. Venook AP, Ferrell LD, Roberts JP (1995) Liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 4: 242–8

    Article  Google Scholar 

  100. Wiesner RM, McDiarmid SV, Kamath PS, et al (2001) Application of MELD and PELD to liver allocation. Liver Transpl 7: 567–80

    Article  CAS  PubMed  Google Scholar 

  101. Yao FY, Ferrell L, Bass NM, et al (2001) Liver transplantation for hepatocellular carcinoma. Hepatology 33: 1394–403

    Article  CAS  PubMed  Google Scholar 

  102. Yoo HY, Galabova V, Edwin D, et al (2002) Socioeconomic status does not affect the outcome of liver transplantation. Liver Transpl 8: 1133–7

    Article  PubMed  Google Scholar 

  103. Yoo HY, Thuluvath PJ (2002) The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 74: 1007–12

    Article  CAS  PubMed  Google Scholar 

  104. Yoshida EM, Erb SR, Partovi N, et al (1999) Liver transplantation for chronic hepatitis B infection with the use of combination lamivuudine and low-dose hepatitis B immune globulin. Liver Transpl Surg 5: 520–5

    Article  CAS  PubMed  Google Scholar 

  105. Zheng S, Chen Y, Liang T, et al (2006) Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B immunoglobulin prophylaxis. Liver Transpl 12: 253–8

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Assistant Professor of Clinical Medicine Presbyterian Hospital 14, Division of Digestive and Liver Diseases, Columbia University 622, West 168th Street, New York, NY, 11032, USA

    Scott A. Fink & Robert S. Brown Jr.

Authors
  1. Scott A. Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert S. Brown Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fink, S.A., Brown, R.S. (2010). Liver Transplantation: Indications, Preoperative Evaluation and Posttransplantation Management. In: Clinical Hepatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04519-6_49

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04519-6_49

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04509-7

  • Online ISBN: 978-3-642-04519-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation